Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000708025 | SCV000837135 | pathogenic | Tuberous sclerosis 2 | 2018-02-21 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 31-42 of the TSC2 gene. The 5' boundary is likely confined to intron 30. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. A similar deletion of exons 31-42 (also known as exons 30-41 in the literature) has been reported in individuals affected with tuberous sclerosis complex (PMID: 17287951). Many different truncations downstream of this variant have been reported to be pathogenic, including a frameshift variant, c.5405_5408dup (p.Phe1803Leufs*42), that has been reported as a disease-causing de novo variant in an individual affected with tuberous sclerosis complex (PMID: 24789117). This suggests that deletion of this region of the TSC2 protein is causative of disease. For these reasons, this variant has been classified as Pathogenic. |